Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04344184 · ClinicalTrials.gov registry record · Phase 2
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT04344184 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 47 participants.
The verdict
NCT04344184, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
This study will evaluate the safety of a 96-hour intravenous vitamin C infusion protocol (50 mg/kg every 6 hours) in patients with hypoxemia and suspected COVID-19.
Interventions
- OTHER Placebo
- DRUG L-ascorbic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2022-06-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04344184
The ClinicalTrials.gov registry entry for NCT04344184 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04344184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04344184 about?
NCT04344184 is a clinical study titled "SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)". This study will evaluate the safety of a 96-hour intravenous vitamin C infusion protocol (50 mg/kg every 6 hours) in patients with hypoxemia and suspected COVID-19.
What is the current status of trial NCT04344184?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2020-12-18. Estimated completion is 2022-06-10.
What interventions are being tested in trial NCT04344184?
The interventions under investigation include: Placebo (OTHER), L-ascorbic acid (DRUG).
Who is sponsoring clinical trial NCT04344184?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.